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Naturally occurring Aleutian disease (AD) of mink is characterized by hyper- 
gammaglobulinemia and lesions resembling many of those described in hyper- 
sensitivity or autoimmune diseases  (1,  2,  7).  There are segmental vasculitis; 
fibrinoid deposition in arterial walls and glomeruli; and marked perivascular 
and parenchymal lymphocyte and plasma  cell infiltration.  Henson et  al.  (1) 
reported absolute  increases in  serum gamma  globulin and  total protein and 
decreased albumin in  mink  with  the natural disease.  Studies of mink on an 
affected ranch have shown a  familial occurrence of hypergammaglobulinemia 
(3). 
Mink  homozygous recessive for the  Aleutian gene symbolized as  (aa)  are 
the usual genotype spontaneously affected, but the disease occasionally occurs 
in those which are heterozygous (Aa)  or homozygous dominant (AA).  When 
these genotypes are present on an  affected ranch,  the  incidence is  highest  in 
aa mink. 
Field observations suggest a marked increase of AD particularly in aa mink 
following the use of formalinized homologous tissue vaccines (2, 4). 
Thus, it would appear that AD  may be a  hypersensitivity or autoimmune 
disease with an apparent genetic as well as familial occurrence. There is also a 
possibility  that  mink,  especialy aa  mink,  may be  unusually  susceptible  to 
certain antigenic stimuli. The investigations reported here were conducted to: 
(a)  produce  experimental hypergammaglobulinemia  in  mink  and  determine 
whether there is a  genetic predilection for its occurrence; (b)  investigate the 
effect of formalin treatment of affected tissue suspensions on the experimental 
production of the disease;  (c)  determine the intensity of circulating gamma 
globulin following antigentic stimulation from various sources; (d)  determine 
whether formalin treatment of normal tissues  from different genotypes alters 
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the  tissue  constituents  sufficiently  to  evoke  hypergammaglobulinemia  when 
these tissues are injected into homologous and heterologous genotypes. 
......  Materials  and Methods 
The 147 mink used in these trials were from our own herd in which spontaneous AD has not 
occurred during a 10-year observation  period. These animals were selected at random as to sex 
and were approximately 2 months Of age when these trials were initiated. The animals were 
paired or maintained individually within treatment groups. They were fed a commercial type 
mink ration and were not vaccinated. The genotypes were assessed by coat  color  and  by 
pedigree (5). 
Blood samples were taken from a lingual vessel (3) prior to inoculation, at monthly intervals 
during the investigations and at the termination of the trials. Only the preinjection samples 
TABLE  I 
Total Number of Animals in  Rack Genotype  and  Treatment and the Number Developing 
Hypergammaglobulinemia 
Group 
A 
B 
C 
D 
E 
F 
G 
H 
Treatment 
Formalin-affected aa, 40 wks. 
Formalin-normal aa, 2 wks. 
Formalin-normal AA, 2 wks. 
Non-formalin affected aa 
Bovine serum albumin, 5 per cent 
Non-injected controls 
Feline tissue, 10 per cent 
Formalin-affected aa, 2 wks. 
Recipient genotypes 
(affected/No. injected) 
aa  Aa  AA 
0/8  0/7  0/8 
0/8  0/7  0/8 
0/8  --*  0/8 
8/8  3/7  4/8 
0/8  --*  0/8 
0/7  0/7  0/8 
0/7  --*  0/4 
5/5  --*  3/8 
Total No. 
affected/total 
No. injected 
0/23 
0/23 
0/16 
15/23 
0/16 
0/22 
0/11 
8/13 
* Insufficient numbers of Aa mink were available to include this genotype in these groups. 
and the final serum samples were used in this paper. The gross and histologic changes will be 
reported at a later date. 
Filter paper electrophoresis was carried out as previously described (1). Duplicate samples 
checked periodically revealed a very close reproducibility of the patterns. 
The affected tissues used for injection were from aa mink with the natural disease obtained 
from a commericail ranch. Normal mink tissues were collected from animals in our own herd. 
In all instances, the spleens, kidneys, and livers were pooled, ground in a Waring blendor and 
diluted to a  10-1 suspension with PSS. The non-formalinized-affected  tissue suspension was 
maintained at -- 26°C until used. The formalinized tissue suspensions were prepared according 
to Hummon and Bushnell (9).  Sufficient formalin was added to give a final concentration of 
0.3 per cent. The formaiinized suspensions were divided and held at 5°C for 2 weeks prior to 
injection. Part of the formalinized affected tissue suspension was maintained under the same 
conditions for 40 weeks. The remaining inocula consisted of bovine serum albumin (5 per cent, 
Armour) and 10  -1 feline pooled tissue suspension prepared from spleen, liver, and intestine. 
All mink were given 3 subcutaneous injections consisting  of 2 ml each of inoculum at 2-week 
intervals. The experiments were terminated 4 months after the initial injections. The treat- 
ment groups, number injected, and genotypes are given in Table I. ~'.  B.  HENSON,  ].  R.  GORHAM,  11.  W.  LEADER;  AND  B.  M.  WAGNER  3S9 
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Statistical analyses were carried out on the data presented  here. The percentage figures were 
converted to arcsin values so that they could be analyzed (10). Analysis of variance was used 
to determine the treatment and genotype effects as well as their interaction. The values for the 
albumin and alpha, beta and gamma globulin fractions were computed separately as an 8 
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FIO. 2. The mean pre- and post-injection serum protein values expressed as percentage of 
total serum proteins according to treatment groups in the 4  treatment (A, B, D, F)-3 geno- 
type (aa, Aa, AA)  analysis. 
treatment-2 genotype (aa and AA) analysis and as a 4 treatment (Groups A, B, D, and F)-3 
genotype (aa, Aa and AA) analysis• The preinjection and the final serum protein values were 
compared on the basis of Least Significant Difference (LSD) (10). 
R~SULTS 
The  results are given as mean  percentage  of the total  serum  proteins  in 
Figs. I  and 2.  The preinjection and final  serum protein values  for  all  the  animals J.  B.  HENSON,  J.  R.  GORHAM,  R.  W.  LEADER,  AND  B.  M.  WAGNER  361 
within each treatment group  are  given separately for the four major serum 
protein fractions. 
The results of the statistical analyses are given in Table II. Because of treat- 
ment effect, a  statistically significant (P  <  0.01)  increase in gamma globulin 
and decrease in albumin were shown in groups D and H. A treatment-genotype 
effect was also demonstrated with a significant (P <  0.01)  increase in gamma 
globulin in genotype aa as compared to the other genotype(s). The number of 
animals by genotypes in each treatment group that developed hypergamma- 
globulinemia is given in Table I. 
TABLE  II 
Summary of Staisti.al Analyses 
Analysis  Gamma globulin  Beta globulin  Alpha globulin  Albumin 
8 Treatment-2 genotype  P  <  o.ox  P  <  o.ni 
(A B  C D  E  F  G H)(aa, AA)  Sig. increase  Sig. decrease 
D  H  D,H 
4 Treatment-3 genotype  P  <  o.ox  P  <  o.oz  P  <  o.oz 
(A B  D  F)  (aa, Aa, AA)  Slg. increase  Sig. decrease  Sig. decrease 
D  AA, Aa genotyp¢  D 
effect 
Treatmeut-genotype interaction  P  <  o.ox  P  <  o.oi  P  <  o.05 
Sig. increase  Sig, decrease  Sig. decrease 
aa-D, H  AA-A, D  ea-H 
Aa-A, D 
Least significant  difference  (pre- 
injection vs. post-injection) 
P  <  o.o5 
Sig. increase 
aa-D, H 
Aa-D 
AA-D, H 
P  <  o.o5 
Sig. decrease 
8 X  2 analysis 
a~-O 
4 X 3 analysis 
a~-D, F 
Aa-A, D 
P  <  o.o5 
Sig. increase 
aa-A, G 
Aa-A, F 
AA-ABCF 
Sig. decrease 
aa-D, H 
The finding of statistically increased albumin in the final serum samples in 
almost all groups  except D  and H  may be  associated with normal protein 
metabolism as a  function of age. It was noted that in groups D  and  H  the 
albumin was  significantly decreased.  The latter is  consistent with the  other 
changes reported here and in the natural disease. The alpha globulin values 
show a definite trend toward lower values in the final serum samples. 
DISCUSSION 
These trials reveal that hypergammaglobulinemia in mink can be evoked by 
the  injection of affected tissue  suspensions  and  a  formalin-treated affected 
tissue suspension held for 2 weeks, but not when held for 40 weeks. The number 
of  mink  developing  hypergammaglobulinemia varied  between  the  different 
genotypes. The number of aa mink developing serum protein changes was sig- 
nificantly higher than the AA  and Aa  genotypes. These findings are similar to 362  HYPERGAMMIAGLOBULINEMIA  IN  MINK 
epizootiologic observations on  the  predominance of  the  spontaneous  disease 
in aa mink. Field observations indicate, however, that when AD becomes estab- 
lished in a herd of AA  or Aa mink, the incidence will increase, thus overriding 
the genetic influence. 
It seems possible  that  the gene for Aleutian coat color is  not directly re- 
sponsible for AD  susceptibility. This gene may be a  convenient marker for a 
group of linked genes in  the residual inheritance that predispose to  the sus- 
ceptibility or resistance to AD. 
The injection of foreign antigens did not induce hypergammaglobulinemia. 
These results indicate  that mink of all genotypes used in  these studies  were 
not hyperresponsive to antigenic stimulation from the tissues used. Moreover, 
formalin treatment did not change normal mink tissue in such a manner as to 
initiate a response in the recipients regardless of genotype. 
Spontaneous disease did not occur in  the mink used in  these trials as  evi- 
denced by the failure of the non-injected control group and all other groups 
except D  and H  to develop serum protein changes. The widespread occurrence 
of natural AD in mink herds makes it necessary to use caution in excluding the 
spontaneous disease in using mink of any color phase. 
Several findings indicate the possible nature of the cause of AD.  Injections of 
formalin-treated  normal  mink  tissue  did  not  cause  altered  serum  proteins. 
Formalin-affected aa tissue was inactivated during 40 weeks'  storage at 5°C. 
Furthermore,  long  term  treatment  with  an  anti-inflammatory  drug  (dexa- 
methasone)  1 has doubled the incidence of spontaneous AD in a large group of 
mink on an affected ranch (6). In our laboratory, cell-free filtrates obtained by 
appropriate  filtration and  centrifugation of  affected tissue  suspensions  have 
produced hypergammaglobulinemia. It appears  that the  cause is  a  filterable 
substance which can be almost completely removed from aqueous suspension 
by ultracentrifugation at 95,000 g for 1 hour. These trials exclude the possibility 
of the  transmission of immunologically competent viable ce~.ls. This work  is 
under study and will be the subject of a future report. 
The initial serum protein changes  can be detected 2  to  3  weeks following 
subcutaneous injection of affected tissue suspensions (6). The gamma globulin 
steadily rises until death ensues--often months following the initial globulin 
change. As anticipated, there is an increasing number of plasma ceils and lym- 
phocytes present  in  the  parenchymatous  organs,  especially around  arteries, 
and  enlarged lymph nodes and  spleen.  Segmental arteritis is  also present in 
some of the more advanced cases.  It is  noteworthy that  the severity of  the 
disease seems to parallel the increase in gamma globulin. It has also been found 
that  the histochemical changes present in  mink  with  AD  resemble many of 
those found in the connective tissue diseases of man  (7). 
It is  difficult to  conceive that  the gamma  globulin is  directed against  the 
1 Azlum, Schering corporation, Bloomfield, New Jersey. J.  B.  HENSON,  J.  R.  GORHAM,  R.  W.  LEADER,  AND  B.  M.  WAGNER  363 
"Aleutian agent" per se.  The mink selected for transfer material were in ad- 
vanced stages of the disease with an accompanying hypergammaglobulinemia. 
If the antibody is homotypic, the "Aleutian agent" may be inaccessible to its 
action.  Another  explanation would be  that  the antibody is  directed against 
another antigen,  conceivably a  tissue antigen.  Neither the mechanism of the 
response nor the relationship of the increased gamma globulin to the patho- 
genesis of the disease is clear. 
Speculation as to the pathogenetic mechanisms involved in AD leads one to 
consider the possibility of an autoimmune disease. If the lesions observed are 
the  result  of  the  activity of  "aggressive"  or  "forbidden" clones  of cells  in 
Burnet's sense (8), such cells might arise by somatic mutation with subsequent 
escape  from  the  normal  body  homeostatic  mechanisms.  Regardless  of  the 
mechanisms  involved, it appears  that  their pathological activity can be ini- 
tiated by a  filterable entity which appears to remain in the animal body in a 
transmissible  form even though  the circulating gamma  globulin levels reach 
extraordinarily high values. This, along with the progression of changes in AD, 
suggests a  "vicious cycle" involving "self" antigens. 
It is interesting to note that  the serum protein levels in  the experimental 
disease can  be held static  or  decreased by the  oral  administration  of dexa- 
methasone. Further, the expression of the disease as manifested by the serum 
protein  changes  can  be  suppressed  by this  drug for months  after mink  are 
injected with  affected tissue  suspensions.  When  the drug is  removed, serum 
protein changes occur (6). 
The transmission mechanism may be very intimate, perhaps in part vertical 
from dam to kittens. Family line studies on an affected ranch have shown over 
twice as many affected offspring from affected dams as compared to unaffected 
dams, but not all kits from an affected dam were diseased; nor were all kits 
from negative dams disease-free (3). 
Aleutian disease of mink may be one of the first described naturally occur- 
ring, transmissible animal diseases that can be used as a  laboratory model in 
studying  the  pathogenetic  mechanisms  involved in  many  immunologic  and 
connective tissue diseases of man. 
SUMM~Ry 
Hypergammaglobulinemia in mink was produced by the injection of crude 
tissue suspensions from mink with spontaneous Aleutian disease. The initiat- 
ing factor was found to be resistant to 0.3 per cent formalin for 2 weeks but not 
40 weeks at 5°C. Foreign antigens as well as formalinized normal mink tissue 
from homologous and heterologous genotypes did not cause a detectable change 
in the serum protein values. 
Mink homozygous recessive for the "Aleutian gene were found to be signifi- 
cantly more susceptible to the experimental disease. 364  HYPERG.AMMAGLOBULINEM'IA  IN  MINK 
Possible pathogenetic mechanisms as well as similarities between the mink 
disease  and  certain immunologic and  connective tissue  diseases  of man  are 
discussed. 
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